The only silver dressing
with cleaning power

  • Description
  • Benefits
  • Indications
  • In Practice
  • FAQs
  • Evidence
  Download product information

 

WHY INFECTED WOUNDS NEED A COMBINED ANTIMICROBIAL AND CLEANING ACTION?

  • Locally infected wounds contain: bacteria, slough, exudate, biofilm and necrotic tissue.
  • The presence of these materials in the wound maintains an ideal environment for bacterial proliferation and biofilm formation[1] and may act as a barrier for any antimicrobial or anti-biofilm proper action of Ag+ ions in the wound.
  • Effectively fighting against local infection requires a combined antimicrobial and cleaning action to remove all materials that may limit the action of the silver ions.
  • Cleaning the wound can reduce the risk of infection, by removing all materials where microorganisms may attach, disseminate and form biofilm thus cause infection.

 

UrgoClean Ag is the only silver dressing
with cleaning power to fight local infection

urgoclean-ag-fights-removes

Mode of action

Structure and composition

UrgoClean Ag is made of two unique technologies clinically proven in randomized controlled trials (RCT).

urgoclean-ag-moa

A combined action to fight local infection: antimicrobial & complete cleaning

  • Strong antimicrobial & anti-biofilm efficacy
  • Complete cleaning action to remove exudate, slough and bacterial residues
[1] Percival SL, Suleman L. Slough and biofilm: removal of barriers to wound healing by desloughing. Journal of Wound Care. 2015 Nov;24(11):498, 500-3, 506-10

This website is an international website. Some products or sizes can therefore be unavailable in some countries. For more information, please contact us.

urgclean-ag-benefits-woundBenefits for the wound

Reduces the bacterial load within the wound and keeps the wound clean from exudate, slough, and bacteria residues.

 

 

urgclean-ag-benefits-hcpBenefits for Health Care Professionals

Effectively fights against local infection with the combined antimicrobial and complete cleaning action and thus avoids complications.

 

urgclean-ag-benefits-patientsBenefits for patients

  • Fights the local infection and avoids complications
  • Is pain-free at removal
  • Is well-tolerated and comfortable

UrgoClean Ag is indicated for the local treatment of exuding wounds at risk or with signs of local infection.

 

urgoclean-ag-indications

CONTRAINDICATIONS

  • Known sensitisation to silver.
  • UrgoClean Ag is not suitable for use as a surgical sponge for heavily bleeding wounds.
  • Do not use UrgoClean Ag in combination with hydrogen peroxide, organomercuric antiseptics or hexamidine.
  • Do not use on patients undergoing Magnetic Resonance Imaging (MRI) examination.

Application guideurgoclean-ag-application

  • Prior to dressing application, clean the wound using saline solution.
  • Remove the protective tabs.
  • Apply the soft-adherent side of UrgoClean Ag to the wound and its contours.
  • If necessary, cover UrgoClean Ag with a secondary dressing suitable for the location of the wound and level of exudate.
  • Hold in place using a fixing bandage.

 

 

 

 

 

UrgoClean Ag dressings should be changed every 1 to 2 days, then as often as required (up to 7 days) depending on the exudate volume and the clinical condition of the wound.

Precautions for use

  • Treatment with UrgoClean Ag should be carried out under medical supervision.
  • Use of this dressing does not negate the need for appropriate systemic anti-bacterial treatment of infected wounds in line with local policy.
  • The soft-adherent Silver Healing Matrix (TLC-Ag) of UrgoClean Ag adheres to latex surgical gloves. It is therefore recommended that the dressing be handled carefully, avoiding any contact with the soft-adherent side or using sterile pliers.
  • Concomitant use with other local treatments is not recommended.
  • Avoid contact with electrodes or conductive gels during electronic measurements, e.g. EEG and ECG.
  • Clinicians / Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates.
  • In the absence of any specific clinical data, use in pregnant or breast-feeding women, is not recommended.
  • Single-use, individual packaging. Re-using a single use dressing may lead to risks of infection.
  • Check that the sterile protector is intact before use.
  • Do not re-sterilise.
  • For elimination, discard according to current protocol. Discard any unused parts of the dressing.

This website is an international website. Some products or sizes can therefore be unavailable in some countries. For more information, please contact us.

HOW TO IDENTIFY LOCAL INFECTION?

Local infection is responsible for signs of bacterial proliferation strictly at the surface of the wound and signs of reactive inflammatory responses.

There are 5 early signs of local infection:

  • Peri-wound erythema
  • Oedema
  • Malodorous wound
  • Pain between dressing changes
  • Purulent and increased volume of exudate

Infection is very likely when 3 or more signs are present.

HOW TO MANAGE INFECTED WOUNDS?

The appropriate management of locally infected wounds involves the management of co-morbidities and a frequent assessment to reduce the bacterial load within the wound. Effectively fighting against local infection requires a combined antimicrobial and complete cleaning action.

UrgoClean Ag, the only silver dressing with cleaning power helps you fight against the local infection.

WHY IS A COMBINED ANTIMICROBIAL AND COMPLETE CLEANING ACTION SO IMPORTANT TO MANAGE LOCAL INFECTION?

A combined antimicrobial and complete cleaning action acts on local wound infection more effectively.

  • It helps reducing bacteria cells concentration by removing all the materials within the wound (slough, biofilm, exudate, debris, etc.) that favour bacterial proliferation.
  • It facilitates complete action of Ag+ ions by removing all barriers and exposing the wound bed directly to antimicrobial agents.
  • It reduces the risk of local infection by cleaning the wound and keeping the wound clean from biofilms which may stimulate inflammation and slough production and from all materials where microorganisms may attach, disseminate and form biofilm[1].

WHAT IS A BIOFILM AND WHY IS IT SO IMPORTANT?

A biofilm is a structured community of microorganisms enclosed in a polymeric matrix attached to the wound surface. Biofilm is a frequent issue: 60% of chronic wound specimens were characterized as containing biofilm (James et al., 2008) and the United States National Institutes of Health says that 80% of chronic infections are biofilm related (Monroe, 2007). Evidence showed that biofilms when present on the wound will delay healing. Thus, we need to remove them from the wound bed before they colonize more areas, which might lead to general infection and life-threatening complications.

DOES THIS PRODUCT KILL ALL TYPES OF BACTERIA?

UrgoClean Ag has indeed proven its efficacy on a wide range of species (bacteria and yeasts).The strains that have been tested are the most commonly involved in infections and include bacterial strains that are resistant to antibiotics such as Methicillin Resistant Staphylococcus aureus (MRSA), Vancomycin Resistant Enteroccoci (VRE) and Extended-Spectrum Beta Lactamases (ESBL).

UrgoClean Ag kills all 40 strains tested within 24 hours so you can be sure of its fast efficacy.

WHEN SHOULD I USE URGOCLEAN AG?

UrgoClean Ag is indicated for the local treatment of exuding wounds at risk or with signs of local infection. You should use UrgoClean Ag after an assessment of the wound if you identify local signs of infection or a high probability to develop a local infection.

CAN I USE URGOCLEAN AG UNDER COMPRESSION BANDAGING?

Yes, UrgoClean Ag can be used under compression bandaging. When using UrgoClean Ag, dressings need to be changed every 1 to 2 days on average to follow the wound evolution and can stay in place for up to 7 days if needed. So does UrgoK2 compression system.

[1] Percival SL, Suleman L. Slough and biofilm: removal of barriers to wound healing by desloughing. Journal of Wound Care. 2015 Nov;24(11):498, 500-3, 506-10

The TLC-Ag matrix and the poly-absorbent fibres have been evaluated in randomized controlled trials (RCT). UrgoClean Ag efficacy, safety and acceptability have been evaluated in a clinical study and many clinical cases.

earth-study-march-2014 UrgoReviewTC23Feb_Web 076_JoWC_2016_25_9_531_538_Bohbot
Evaluation of two fibrous wound dressings for the management of leg ulcers: Results of a European randomised controlled trial (EARTH RCT) Efficacy of a silver lipidocolloid dressing on heavily colonised wounds: a republished RCT Clinical evaluation of a dressing with poly absorbent fibres and a silver matrix for managing chronic wounds at risk of infection: a non comparative trial
Download Download Download
Last update : November 23, 2017